Perisynaptic Astrocytic Processes Research Articles

Neurodegeneration in Niemann-Pick type C disease mice.

Niemann-Pick disease type C (NP-C) is an inherited neurodegenerative disorder associated with intracellular cholesterol and glycolipid trafficking defects. Two separate genes, NPC1 and NPC2, have been linked to NP-C. NPC1 encodes a polytopic membrane-bound protein with a putative sterol-sensing domain. NPC2 has been recently identified as epididymal secretory glycoprotein 1. The NPC1 protein functions in the vesicular redistribution of endocytosed lysosomal cargo, but how its inactivation leads to neurodegeneration is not known. The neurological symptoms of NP-C typically appear after a period of normal early development and reflect progressive degeneration of widespread brain regions. Here we have delineated the pattern of neurodegeneration in NP-C mice, whose genetic defect has been shown to be an inactivating mutation of the mouse NPC1 gene. The results reveal a spatially and temporally specific pattern of degeneration of nerve fibers followed by degeneration of neuronal cell bodies beginning as early as day 9 and continuing throughout life. We have recently showed that in the primate brain, the NPC1 protein is localized predominantly within perisynaptic astrocytic processes. The present observations suggest that a functional disturbance in NPC1 could disrupt vesicular transport of cholesterol, glycolipids and possibly other endocytic cargo in glia, which is critical for maintaining the integrity of neurons.

Topical correlation of increased hippocampal glutamine synthetase immunoreactivity and glutamatergic terminal fields after entorhinal cortex lesion.

Many astrocyte functions are related to glutamatergic transmission and to other synaptic functions, such as glutamate uptake and glutamate metabolism. While many of these functions can be executed by perisynaptic astrocyte processes, it is not clear how these processes are formed. One of the factors guiding them to the synapse may be synaptically released glutamate. This would explain the topical correlation between laminated glutamatergic terminal fields and laminae most intensely labeled by a cytoplasmic astrocyte marker, anti-glutamine synthetase (GS). This hypothesis was tested by selectively increasing the glutamate content in one terminal field. The rat entorhinal cortex, the origin of the glutamatergic projection to the outer molecular layer (OML) of the hippocampal fascia dentata, was lesioned electrolytically. In line with the hypothesis, GS immunoreactivity was strongly increased in the OML at 6 and 8 days postlesion. Lesion of only the medial entorhinal cortex resulted in heavily increased GS immunoreactivity only in the central portion of the molecular layer (i.e., the corresponding terminal field). The laminae affected were always separated from neighboring fields by a straight and clear-cut line. Although many other factors are released in the terminal field after lesion, the results are consistent with a guiding role for glutamate. The lamina-specific effect suggests that the factor(s) involved have a very limited diffusion distance. The straight border line between affected and unaffected laminae, which cuts across astrocyte territories, can best be explained by ramification of only those processes of a given astrocyte that are contained within the lamina affected.

The Golgi apparatus is present in perisynaptic, subependymal and perivascular processes of astrocytes and in processes of retinal Müller glia

The Golgi apparatus (GA) of innervated rat and chicken skeletal muscle is present in a typical perinuclear location, and in subsynaptic areas where it disperses after denervation. It was suggested that the subsynaptic segments of the GA are linked with functions involved in the maturation and targeting of synaptic proteins. Similarly, the GA of rat myocardium is found in a perinuclear location and between myofibrils, adjacent to the T system of tubules. These findings raise the question whether the GA of polarized cells is present in a typical perinuclear location, for the performance of general “housekeeping” functions, and in distal areas, for the mediation of specialized functions. Astrocytes may contain GA within their long cytoplasmic processes which are difficult to identify in thin sections. To ensure the astrocytic origin of GA in otherwise unidentifiable small processes, we used transgenic mice expressing the rat MG160 medial Golgi sialoglycoprotein only in the GA of astrocytes, and visualized the GA with monoclonal antibody 10A8 (mAb10A8) which reacts only with rat MG160. Thus, we identified cisternae of the GA in distal perisynaptic and subependymal processes, in perivascular foot plates of cerebral astrocytes, and in processes of the Müller glia in the retina. A similar strategy may be adopted in future investigations aiming at the detection of elements of the GA in distal processes of neurons and oligodendrocytes. The functional implications of GA in perisynaptic astrocytic processes and other processes are unknown. However, the isolation and molecular characterization of the perisynaptic subset of astrocytic Golgi may be feasible, since others have purified the astrocytic glutamate transporter 1 (GLT1) from crude synaptosomal fractions in which astrocytic processes are probably unavoidable contaminants.

Regional distribution of NPC1 protein in monkey brain.

NPC1 is a member of a family of polytopic membrane-bound proteins with sterol-sensing domains. Inactivating mutations of NPC1 are responsible for most cases of Niemann-Pick type C disease, whose hallmark is progressive neurodegeneration. The precise molecular mechanisms whereby defective NPC1 function leads to neurodegeneration are unknown. In the brain, we have previously found NPC1 to localize predominantly within perisynaptic astrocytic processes. Here we have mapped the regional distribution of NPC1 in the monkey brain. Dense NPC1 immunoreactivity was observed in telencephalic structures, including the cerebral neocortex, hippocampus, caudate nucleus and putamen, whilst light immunostaining was observed in diencephalic structures, including the globus pallidus, thalamus and hypothalamus. Light staining was also generally observed in the midbrain, pons, medulla oblongata and cerebellum, except the inferior olive, which was densely stained. By light microscopy, only a few indistinctly labeled cell bodies were observed even within densely labeled regions, where most of the immunoreactivity appeared to be due to the large numbers of labeled cellular processes. On electron microscopy, these processes were identified as glial, and not neuronal. The astrocytic localization of NPC1 was further confirmed by double labeling for NPC1 and GFAP. The regional pattern of NPC1 expression suggests that areas normally expressing low levels of the NPC1 protein are more susceptible to neuronal degeneration in Niemann-Pick type C disease.

Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease.

Niemann-Pick type C disease (NP-C) is an inherited neurovisceral lipid storage disorder characterized by progressive neurodegeneration. Most cases of NP-C result from inactivating mutations of NPC1, a recently identified member of a family of genes encoding membrane-bound proteins containing putative sterol sensing domains. By using a specific antipeptide antibody to human NPC1, we have here investigated the cellular and subcellular localization and regulation of NPC1. By light and electron microscopic immunocytochemistry of monkey brain, NPC1 was expressed predominantly in perisynaptic astrocytic glial processes. At a subcellular level, NPC1 localized to vesicles with the morphological characteristics of lysosomes and to sites near the plasma membrane. Analysis of the temporal and spatial pattern of neurodegeneration in the NP-C mouse, a spontaneous mutant model of human NP-C, by amino-cupric-silver staining, showed that the terminal fields of axons and dendrites are the earliest sites of degeneration that occur well before the appearance of a neurological phenotype. Western blots of cultured human fibroblasts and monkey brain homogenates revealed NPC1 as a 165-kDa protein. NPC1 levels in cultured fibroblasts were unchanged by incubation with low density lipoproteins or oxysterols but were increased 2- to 3-fold by the drugs progesterone and U-18666A, which block cholesterol transport out of lysosomes, and by the lysosomotropic agent NH4Cl. These studies show that NPC1 in brain is predominantly a glial protein present in astrocytic processes closely associated with nerve terminals, the earliest site of degeneration in NP-C. Given the vesicular localization of NPC1 and its proposed role in mediating retroendocytic trafficking of cholesterol and other lysosomal cargo, these results suggest that disruption of NPC1-mediated vesicular trafficking in astrocytes may be linked to neuronal degeneration in NP-C.

The remote astroglial response (RAR): a holistic approach for evaluating the effects of lesions of the central nervous system.

The right dorsal lateral geniculate nucleus was stereotaxically destroyed in adult albino rats. After 3 to 150 days of survival the visual cortices from both hemispheres were processed for semithin histology, electron microscopy, GFAP immunohistochemistry and immunoblotting. In visual cortices with histologically disclosed degeneration of the geniculo-cortical tract, a hypertrophy of astrocytes without change in their total numbers was seen from postoperative day 3. From day 7, a rise in GFAP immunoreactivity was observed, reaching its peak between days 11-14, after which a decrease occurred. Observations were confirmed by computer-assisted image analysis of immunohistochemical preparations. Using the immunoblot technique, relative GFAP levels were found to change in a fashion similar to immunohistochemical findings. This showed that synaptic degeneration triggered an up-regulation of GFAP synthesis in the perisynaptic astrocyte processes as a second, cytoskeletal phase of the astrocyte reaction. The phenomenon is denoted as the remote astroglial response (RAR) and is thought to be a marker of synapse removal during plastic changes either related to function or induced by lesions. An extrapolation is made to the possible significance of whole-brain GFAP levels in assessing the effects of focal CNS lesions.

Astroglial processes around identified glutamatergic synapses contain glutamine synthetase: evidence for transmitter degradation

Glutamate is the main excitatory transmitter in the cerebral cortex. The physiologically high spatial and temporal resolution in glutamatergic transmission requires effective transmitter removal. Thus, a close topochemical relation to the glutamatergic synapse is a prerequisite for an enzyme involved in glutamate transmitter degradation. Here we report that immunoreactivity against glutamine synthetase (GS), one of the glutamate metabolizing enzymes, is localized in the fine astrocytic processes associated with identified glutamatergic synapses in the rat hippocampus. We suggest that glutamate transmitter is rapidly taken up by these fine perisynaptic astrocytic processes and degraded by GS.